Home › Familial Amyloidosis › Texas
Familial Amyloidosis clinical trials in Texas
4 studies for Familial Amyloidosis are looking for participants at sites in Texas.
Cities in Texas
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern Medical Center, Dallas
- Baylor College of Medicine, Houston
- and 2 more
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Nov 4, 2026 · NCT06128629ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Austin
- Clinical Trial Site, Houston
RecruitingObservational study
All ages · All sexes · Updated Oct 13, 2026 · NCT04561518Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Dallas
- Research Site, Houston
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
- University of Texas Southwestern Medical Center, Dallas
RecruitingObservational study
Ages 30 to 80 · All sexes · Updated Aug 31, 2026 · NCT05489549From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.